ImmusanT
Latest round
- Series C
Last raised
- Nov 2017
Total raised
- $20M
Investors
- 2
About ImmusanT
Founded in 2010 and based in Massachusetts, US, ImmusanT, Inc. is a biotechnology company that focuses on developing therapies for the treatment of celiac disease.
Who invested in ImmusanT
2 investors across 1 round
See all investors in ImmusanT
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Nov 14, 2017
Amount
$20M
Investors
Questions about ImmusanT
Who invested in ImmusanT?
ImmusanT has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ImmusanT raised?
ImmusanT has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did ImmusanT last raise money?
ImmusanT's most recent round on record is a Series C, in Nov 2017.
What does ImmusanT do?
Founded in 2010 and based in Massachusetts, US, ImmusanT, Inc.
Where is ImmusanT headquartered?
ImmusanT is headquartered in Cambridge, US.
Which VCs invest in companies like ImmusanT?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at ImmusanT's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like ImmusanT? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.